Abate, Andargie
Bouyssou, Isabelle
Mabilotte, Solenne
Doderer-Lang, Cecile
Dembele, Laurent
Menard, Didier
Golassa, Lemu
Funding for this research was provided by:
The Bill and Melinda Gates Foundation (INV-015996, INV-015996, INV-015996, INV-015996, INV-015996, INV-015996, INV-015996)
European and Developing Countries Clinical Trials Partnership
Malaria Genetics and Resistance Unit, Department of Parasites and Insect Vectors of Pasteur Institute, Paris, France
Article History
Received: 2 June 2022
Accepted: 26 July 2022
First Online: 1 August 2022
Declarations
:
: Ethical clearance was obtained from the Institutional Review Board of Addis Ababa University, Aklilu Lemma Institute of Pathobiology (Ref. no. ALIPB IRB/18/2012/20), and National Research Ethics Review Committee (Ref. no. MoSHE/02/152/778/21). Study participants, their parents, or guardians had gotten detailed explanations about their rights, purpose, procedure, and benefit of the study and side effects of the procedure and written informed consent was also obtained. In addition, assent was obtained from children. The study participants were treated according to the national treatment guideline. All participants were assured of confidentiality throughout the study.
: Not applicable.
: The authors declare that they have no competing interests.